Bioventix (LON:BVXP) Stock Passes Above Fifty Day Moving Average – What’s Next?

Bioventix PLC (LON:BVXP)’s stock price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 1,663.31 and traded as high as GBX 1,700. Bioventix shares last traded at GBX 1,660, with a volume of 5,318 shares traded.

Bioventix Stock Down 0.9%

The firm’s 50-day moving average is GBX 1,663.31 and its 200-day moving average is GBX 1,738.37. The company has a market capitalization of £86.74 million, a PE ratio of 11.81 and a beta of 0.56.

Bioventix (LON:BVXP) last posted its quarterly earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. The business had revenue of GBX 615.88 billion during the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. As a group, equities research analysts predict that Bioventix PLC will post 166.3066955 EPS for the current year.

Insiders Place Their Bets

In other Bioventix news, insider Peter John Harrison purchased 1,065 shares of the stock in a transaction on Wednesday, April 8th. The stock was acquired at an average cost of GBX 1,849 per share, with a total value of £19,691.85. Also, insider Ian James Nicholson purchased 1,000 shares of the stock in a transaction on Friday, April 10th. The stock was acquired at an average cost of GBX 1,848 per share, with a total value of £18,480. Insiders acquired 2,131 shares of company stock valued at $3,927,999 over the last three months. Insiders own 6.16% of the company’s stock.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.